H

HUMA

HUMA

UnknownUnknown

Company information not available. Track real-time insider trading activity, SEC Form 4 filings, and executive stock transactions.

Insider Sentiment
Based on recent trading activity
40%Neutral
Buy/Sell Ratio1% buys
BearishBullish
HUMA Live QuoteReal-time
$0.54
+$0.13(+32.32%)1M
Day Range$0.52 – $0.58
Open$0.52
Previous Close$0.50
Volume3.74M
Key Financials & Valuation
Fundamental balance sheet & market metrics
HEALTHCARE
Market Cap$138.90M
P/E Ratio (TTM)24.5
Forward P/E35.8
EPS (TTM)$-0.45
Price to Book7.7
Dividend Yield0.65%
Beta (Volatility)2.68
IndustryBIOTECHNOLOGY
52-Week RangeCurrent: $0.54 (17%)
Low: $0.34High: $1.52
Wall Street Consensus
Sell
Analyst Rating
2.2/ 5.0
Target Price
$1.64-98.9% upside

Insider Buys

14

$272K

Insider Sales

6

$20.76M

Total Volume

$21.03M

33 transactions

Net Activity

$20.49M

Net selling

Proprietary Ratings
Calculated from Form 4 transactions
70CONFIDENCE

Sentiment Rating

Moderate Accumulation

CEO Conviction Index

High Conviction Accumulation

Key Drivers

  • •Heavy distribution: sales represent 99% of total transaction value.
  • •Cluster buying: 9 unique insiders purchased shares, showing strong alignment.
  • •CEO buying activity detected. When chief executives put their own money at risk, it is historically a strong bullish signal.
  • •CFO buying activity detected. Statistical studies show CFO purchases have high predictive power due to their direct visibility into balance sheet details.
  • •Significant liquidation: total sale value exceeds $10M.
Score Methodology

The Insider Confidence Score (1-100) measures executive conviction. Starting from a neutral 50, it adjusts based on:

  • +15Strong Buy Ratio: Purchases > 70% of volume (or up to -15 for heavy sales).
  • +20Cluster Buying: ≥3 unique insiders buying within a 30-day window.
  • +15CEO Buying: CEO committing own capital shows high conviction.
  • +10CFO Buying: CFO purchasing shares shows financial alignment.
Top Insiders
Most active traders
M
1

Multiple Insiders

P - Purchase Insiders

0 buys13 sells

$23.38B total

D
2

Dougan Brady W

Dir

1 buys2 sells

$10.35M total

N
3

Niklason Laura E

Pres, CEO, Dir

1 buys2 sells

$10.35M total

S
4

Sebelius Kathleen

Dir

2 buys0 sells

$116K total

S
5

Sander Dale A.

CFO, Chief Corp. Dev. Off

1 buys1 sells

$72K total

Trading History
HUMA insider transactions from SEC Form 4 filings
DateInsiderTypeSharesPriceValueFiling

Sep 14, 2026

2 months ago

Jones Keith Anthony

Dir

Director
Buy10.0K$0.56$6K

Sep 14, 2026

2 months ago

Multiple Insiders

P - Purchase Insiders

Insider
Sell50.0K$10000.00$500.00M

Aug 20, 2026

3 months ago

Jones Keith Anthony

Dir

Director
Buy10.0K$0.69$7K

Aug 20, 2026

3 months ago

Multiple Insiders

P - Purchase Insiders

Insider
Sell40.0K$10000.00$400.00M

Aug 17, 2026

3 months ago

Jones Keith Anthony

Dir

Director
Buy30.0K$0.59$18K

Aug 17, 2026

3 months ago

Multiple Insiders

P - Purchase Insiders

Insider
Sell30.0K$30000.00$900.00M

May 19, 2026

6 months ago

Sebelius Kathleen

Dir

Director
Buy56.8K$0.88$50K

May 19, 2026

6 months ago

Multiple Insiders

P - Purchase Insiders

Insider
Sell148.0K$56818.00$8.41B

May 18, 2026

6 months ago

Multiple Insiders

P - Purchase Insiders

Insider
Sell44.0K$11000.00$483.45M

May 18, 2026

6 months ago

Constantino Michael T.

Dir

Director
Buy11.0K$0.89$10K

May 18, 2026

6 months ago

Sander Dale A.

CFO, Chief Corp. Dev. Off

CFO
Sell45.9K$0.90$41K

May 18, 2026

6 months ago

Parikh Shamik J

Chief Medical Officer

C-Level
Sell45.9K$0.90$41K

Aug 18, 2025

15 months ago

Dougan Brady W

Dir

Director
Sell2.24M$1.67$3.73M

Aug 18, 2025

15 months ago

Niklason Laura E

Pres, CEO, Dir

CEO
Sell2.24M$1.67$3.73M

Aug 18, 2025

15 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell1.39M$-2241045.00$0

Apr 14, 2025

19 months ago

Multiple Insiders

P - Purchase Insiders

Insider
Sell22.0K$6493.00$142.96M

Apr 14, 2025

19 months ago

Scheessele William John

Chief Commercial Officer

C-Level
Buy6.5K$1.54$10K

Apr 10, 2025

19 months ago

Multiple Insiders

P - Purchase Insiders

Insider
Sell42.6K$20000.00$852.00M

Apr 10, 2025

19 months ago

Parikh Shamik J

Chief Medical Officer

C-Level
Buy7.5K$1.55$12K

Apr 10, 2025

19 months ago

Sander Dale A.

CFO, Chief Corp. Deve. Officer

CFO
Buy20.0K$1.53$31K

Apr 8, 2025

19 months ago

Green Charles Bruce

Dir

Director
Buy6.0K$1.29$8K

Apr 8, 2025

19 months ago

Multiple Insiders

P - Purchase Insiders

Insider
Sell91.2K$50000.00$4.56B

Apr 7, 2025

19 months ago

Multiple Insiders

P - Purchase Insiders

Insider
Sell33.0K$16000.00$527.20M

Apr 8, 2025

19 months ago

Sebelius Kathleen

Dir

Director
Buy50.0K$1.32$66K

Apr 7, 2025

19 months ago

Constantino Michael T.

Dir

Director
Buy16.0K$1.26$20K

Dec 4, 2024

23 months ago

Multiple Insiders

P - Purchase Insiders

Insider
Sell16.9K$4600.00$77.97M

Dec 4, 2024

23 months ago

Constantino Michael T.

Dir

Director
Buy4.6K$4.39$20K

Nov 19, 2024

24 months ago

Multiple Insiders

P - Purchase Insiders

Insider
Sell3.63M$1797.00$6.53B

Nov 19, 2024

24 months ago

Dougan Brady W

Dir

Director
Buy1.8K$4.44$8K

Nov 19, 2024

24 months ago

Niklason Laura E

Pres, CEO, Dir

CEO
Buy1.8K$4.44$8K

Nov 18, 2024

24 months ago

Dougan Brady W

Dir

Director
Sell1.50M$4.40$6.61M

Nov 18, 2024

24 months ago

Niklason Laura E

Pres, CEO, Dir

CEO
Sell1.50M$4.40$6.61M

Nov 18, 2024

24 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell3.63M$-1500000.00$0
Sector & Industry Benchmarks
Unknown Comparison Overview
Industry Buy Conviction6%
HUMA Buy Conviction1%
Industry Rank#0 of 570
Volume Contribution0.1%
Total Industry Activity$16.44B

HUMA has an insider buy conviction of 1%, compared to the Unknown sector buy average of 6%.

Insider Trading Summary & Commentary
Automated executive transaction analysis for HUMA

Over the last 90 days, corporate insiders at HUMA (HUMA) engaged in a total of 33 transactions reported via SEC Form 4 filings. Among these, 14 were open-market purchases and 6 were sales. The total volume of insider trading reached $21.03M.

The net insider activity for HUMA shows a net selling bias of $20.49M. This activity represents a 1% buy ratio, suggesting that insiders are currently bearish on the company's near-term outlook relative to recent history.

The most notable individual transaction was a Sale by Multiple Insiders (P - Purchase Insiders), who traded 148.0K shares valued at $8.41B on May 19, 2026.

Live Market News & Developments
Aggregated real-time headlines for HUMA (HUMA)
6 updates

Humacyte(HUMA) Stock Options Chain | Quotes & News

Moomoo3d ago

Humacyte, Inc. (HUMA) Stock Drops Despite Market Gains: Important Facts to Note

Yahoo Finance49d ago

Humacyte Submits Supplemental Biologics License Application to FDA for the Acellular Tissue Engineered Vessel in Dialysis Access

Stock Titan10h ago

Humacyte, Inc. (HUMA) Stock Slides as Market Rises: Facts to Know Before You Trade

Yahoo Finance44d ago

Humacyte Stock (HUMA) Opinions on Phase 3 Trial Results

Moomoo91d ago

Humacyte, Inc. (HUMA) Sees a More Significant Dip Than Broader Market: Some Facts to Know

Yahoo Finance37d ago

FAQs About HUMA Insider Trading

Answers to common questions regarding corporate filings and executive sentiment for HUMA.

Based on SEC Form 4 disclosures, the Insider Confidence Score for HUMA is currently 70/100, which reflects a moderate accumulation bias. This calculation accounts for a total of 14 purchases and 6 sales by company executives over the last 90 days.

The CEO Conviction Index for HUMA is rated as "High Conviction Accumulation". Executive buying is typically a strong vote of confidence as C-level leaders have the most intimate knowledge of their firm's prospects. Officer selling, on the other hand, is often routine and does not automatically signal operational weakness.

No. Insider tracking is a highly informative technical signal that indicates executive sentiment, but it should not be the sole basis for a transaction. Investors should combine this filing analysis with company financials, sector trends, and risk management criteria.